MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Clinicopathologic features of primary lateral sclerosis with TDP-43 presenting as atypical parkinsonism

    A. Murakami, S. Koga, S. Fujioka, K. Bieniek, H. Sekiya, M. Nakamura, Y. Tsuboi, M. Murray, Z. Wszolek, D. Dickson (Jacksonville, USA)

    Objective: To clarify clinicopathologic features of pathologically-confirmed primary lateral sclerosis (PLS). Background: PLS is a neurodegenerative disorder characterized by slowly progressive upper motor neuron signs…
  • 2022 International Congress

    Deep Brain Stimulation in Generalized Dystonia Caused by PRKRA Mutation

    A. Falcone, C. Listik, S. Barbosa Casagrande, M. Torres, D. Boari Coelho, L. Augusto Teixeira, J. Papaterra Limongi, M. Jacobsen Teixeira, E. Reis Barbosa, R. Cury (Caçapava, Brazil)

    Objective: Dystonia is a hyperkinetic movement disorder with a complex pathophysiology. The medical treatment includes pharmacological treatment, including botulinum toxin (BoNT), which is considered the…
  • 2022 International Congress

    Noninvasive focal delivery of Adeno Associated Vectors (AAV) with magnetic resonance-guided focused ultrasound in non-human primates

    J. Blesa, JA. Pineda-Pardo, K. Inoue, T. Balzano, N. Lopez Gonzalez-Del-Rey, A. Reinares-Sebastian, N. Esteban-Garcia, I. Trigo-Damas, M. Takada, JA. Obeso (MOSTOLES, Spain)

    Objective: Focal brain delivery of gene therapy in non-human primates is a major step towards the translation of this technology for use in humans. We…
  • 2022 International Congress

    Use of alternative healing for Parkinson’s disease in Kenya

    N. Fothergill-Misbah, R. Walker (Southampton, United Kingdom)

    Objective: To explore the experience of alternative healing practices by people with Parkinson’s disease in Kenya. Background: As a neurodegenerative condition, Parkinson’s disease (PD) requires…
  • 2022 International Congress

    Systematic mapping of Parkinson’s disease gene interactions

    P. Antony, J. Forster, O. Kondratyeva, S. Köglsberger, R. Krüger (Belvaux, Luxembourg)

    Objective: Here, we aim to identify functional interactions between the Parkinson’s disease-associated genes. Background: Understanding how genes interact to produce a given phenotype is a…
  • 2022 International Congress

    Understanding the continuing educational needs of US clinicians managing OFF episodes in Parkinson’s disease

    W. Cerenzia, S. Wiley, B. Coleman, S. Stacy, E. Jen, K. Farahmand (Birmingham, USA)

    Objective: This study sought to understand the continuing medical education (CME) needs of US-practicing neurologists (NEUROs) and neurology advanced practice providers (APPs) in managing patients with Parkinson’s Disease (PD) experiencing…
  • 2022 International Congress

    Late-onset Treatment Resistant Isolated Oromandibular Dystonia: A case report

    S. Jain, P. Renjen, D. Chaudhary, S. Pandey, A. Goswami (New Delhi, India)

    Objective: We hereby report a case of oromandibular dystonia with onset in late 70s and symptoms resistant to symptomatic therapy including onabotulinum toxin A. Background:…
  • 2022 International Congress

    Antipsychotic use in Parkinson’s disease: a single center retrospective chart review

    S. Brooker, C. Yeh, D. Larson (Chicago, USA)

    Objective: To assess the prevalence of antipsychotic (AP) use in people with Parkinson’s disease (PwP), and identify factors associated with AP prescription and differences in…
  • 2022 International Congress

    Giant symptomatic capillary telangiectasia: uncommon cause of cerebellar ataxia

    A. Fernández Revuelta, V. Gómez Mayordomo, M. Hernández Holgado, M. Fernández García, A. Baltasar Corral, E. López Valdés, R. García-Ramos (Madrid, Spain)

    Objective: We present a case of a patient with adult-onset cerebellar ataxia and palatal tremor secondary to an uncommon vascular cause. Background: Capillary telangiectasias (CT)…
  • 2022 International Congress

    Emotion Recognition in Multiple System Atrophy – an Eye-Tracking Study

    V. Sidoroff, F. Carbone, P. Ellmerer, S. Bair, A. Hoffmann, T. Maran, C. Raccagni, K. Seppi, G. Wenning, A. Djamshidian-Tehrani (6020, Austria)

    Objective: To get better insights into emotion processing in patients with MSA-P compared to healthy controls (HCs) by using two different Eye-Tracking paradigms. Background: MSA…
  • « Previous Page
  • 1
  • …
  • 658
  • 659
  • 660
  • 661
  • 662
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley